Cargando…
Fighting rare cancers: lessons from fibrolamellar hepatocellular carcinoma
The fight against rare cancers faces myriad challenges, including missed or wrong diagnoses, lack of information and diagnostic tools, too few samples and too little funding. Yet many advances in cancer biology, such as the realization that there are tumour suppressor genes, have come from studying...
Autor principal: | Simon, Sanford M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022574/ https://www.ncbi.nlm.nih.gov/pubmed/36932129 http://dx.doi.org/10.1038/s41568-023-00554-w |
Ejemplares similares
-
Non coding RNA analysis in fibrolamellar hepatocellular carcinoma
por: Farber, Benjamin A., et al.
Publicado: (2017) -
Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
por: Shebl, Bassem, et al.
Publicado: (2022) -
Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event
por: Abdelhamed, Walaa, et al.
Publicado: (2022) -
Mixed fibrolamellar hepatocellular carcinoma
por: Limaiem, Faten, et al.
Publicado: (2021) -
Oncogenic Addiction of Fibrolamellar Hepatocellular Carcinoma to the Fusion Kinase DNAJB1-PRKACA
por: Neumayer, Christoph, et al.
Publicado: (2023)